An overview of the safety and tolerance of glimepiride

Hormone and Metabolic Research

Volumn 28, Issue 9, 1996, Pages 413-418

  Schneider, J ^a  

^a NONE   (United States)

Author keywords

Deaths, discontinuations, and serious events (DDOS); Safety; Treatment emergent signs and symptoms (TESS)

Indexed keywords

GLIBENCLAMIDE; GLIMEPIRIDE; PLACEBO;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT INFECTION;

EID: 0029805442     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979829     Document Type: Conference Paper

References (3)

1. Draeger, E.: Glimepiride: Clinical profile of glimepiride. Diab. Res. Clin. Pract. 28 (Suppl): S139-S146 (1995)
2. Gerich, J. E.: Oral hypoglycemic agents. N. Engl. J. Med. 321: 1231-1245 (1989)
3. Groop, L. C.: Sulfonylureas in NIDDM. Diabetes Care 15: 737-754 (1992)